Rheumatologic serologies: Difference between revisions
From IDWiki
(Imported from text file) |
No edit summary |
||
| Line 1: | Line 1: | ||
| + | {| class="wikitable" |
||
| − | {| |
||
| − | ! |
+ | !Test |
| − | ! |
+ | !Association |
| − | ! |
+ | !Correlates with dz activity? |
|- |
|- |
||
| − | | |
+ | |ANA |
| − | | |
+ | |[[SLE]] |
| − | | |
+ | |No |
|- |
|- |
||
| − | | |
+ | |ANA (centromere pattern) |
| − | | |
+ | |[[CREST syndrome]], [[Systemic sclerosis|SSc]], PH |
| |
| |
||
|- |
|- |
||
| − | | |
+ | |Anti-Smith |
| − | | |
+ | |[[SLE]] (most specific) |
| − | | |
+ | |No |
|- |
|- |
||
| − | | |
+ | |Anti-dsDNA |
| − | | |
+ | |[[SLE]] |
| − | | |
+ | |Yes, especially renal disease |
|- |
|- |
||
| − | | |
+ | |Anti-histone |
| − | | |
+ | |[[Drug-induced lupus]] |
| |
| |
||
|- |
|- |
||
| − | | |
+ | |Anti-U1-RNP |
| − | | Mixed CTD |
+ | |[[Mixed connective tissue disease|Mixed CTD]] |
| |
| |
||
|- |
|- |
||
| − | | |
+ | |Anti-Ro/SSA |
| − | | |
+ | |[[Sjögren syndrome]]<br />Neonatal heart block<br />[[Systemic lupus erythematosus|Subacute SLE]] |
| |
| |
||
|- |
|- |
||
| − | | |
+ | |Anti-La/SSB |
| − | | |
+ | |[[Sjögren syndrome]]<br />Sicca syndrome<br />[[Neonatal lupus|Neonatal SLE]] |
| |
| |
||
|- |
|- |
||
| − | | |
+ | |Anti-Scl-70 |
| − | | SSc and pulmonary fibrosis, dcSSc |
+ | |[[Systemic sclerosis|SSc and pulmonary fibrosis]], [[Systemic sclerosis|dcSSc]] |
| |
| |
||
|- |
|- |
||
| − | | |
+ | |Anti-Jo-1 |
| − | | |
+ | |[[Polymyositis]]<br />[[Antisynthetase syndrome]] |
| |
| |
||
|- |
|- |
||
| − | | |
+ | |Anti-CCP |
| − | | RA (most specific) |
+ | |[[Rheumatoid arthritis|RA]] (most specific) |
| |
| |
||
|- |
|- |
||
| − | | |
+ | |Anti-smooth muscle |
| − | | |
+ | |[[Autoimmune hepatitis]] |
| |
| |
||
|- |
|- |
||
| − | | |
+ | |Anti-PR3 (cANCA) |
| + | |[[Granulomatosis with polyangiitis|GPA]] |
||
| − | | GPA |
||
| |
| |
||
|- |
|- |
||
| − | | |
+ | |Anti-MPO (pANCA) |
| + | |[[Microscopic polyangiitis|MPA]] and [[Eosinophilic granulomatosis with polyangiitis|eGPA]] |
||
| − | | MPA and eGPA |
||
| |
| |
||
|} |
|} |
||
Revision as of 15:24, 19 August 2020
| Test | Association | Correlates with dz activity? |
|---|---|---|
| ANA | SLE | No |
| ANA (centromere pattern) | CREST syndrome, SSc, PH | |
| Anti-Smith | SLE (most specific) | No |
| Anti-dsDNA | SLE | Yes, especially renal disease |
| Anti-histone | Drug-induced lupus | |
| Anti-U1-RNP | Mixed CTD | |
| Anti-Ro/SSA | Sjögren syndrome Neonatal heart block Subacute SLE |
|
| Anti-La/SSB | Sjögren syndrome Sicca syndrome Neonatal SLE |
|
| Anti-Scl-70 | SSc and pulmonary fibrosis, dcSSc | |
| Anti-Jo-1 | Polymyositis Antisynthetase syndrome |
|
| Anti-CCP | RA (most specific) | |
| Anti-smooth muscle | Autoimmune hepatitis | |
| Anti-PR3 (cANCA) | GPA | |
| Anti-MPO (pANCA) | MPA and eGPA |
References
- ^ B. Hervier, M. Rimbert, F. Colonna, M. A. Hamidou, M. Audrain. Clinical significance of anti-Ro/SSA-52 kDa antibodies--a retrospective monocentric study. Rheumatology. 2009;48(8):964-967. doi:10.1093/rheumatology/kep145.
